Literature DB >> 31388249

Summary of the Highlights of 2019 ASTCT Meeting by iNDUS BMT Group at Chennai, India.

Ajay Sharma1, Biju George2, Chezian Subhash3, Dinesh Bhurani4, Dharma Choudhary5, Jose Easow6, Joseph John7, Lalit Kumar8, Neeraj Sidharthan9, Pankaj Malhotra10, Rayaz Ahmed4, Revathy Raj6, Rahul Bhargava11, Satya Prakash Yadav12, Sharat Damodar13, Soniya Nityanand14, Sunil Bhat13, Tapan Saikia15, Tulika Seth8, Velu Nair16, Vikram Mathews2.   

Abstract

This article summarises the main highlights of the abstracts presented at the annual meeting of American Society of Transplantation and Cellular Therapy (ASTCT). The highlights of ASTCT meeting were organised by iNDUS BMT group in Chennai, India. The purpose of the highlight meeting was to educate the students about the latest research in the field of hematopoietic stem cell transplantation and its applicability for the developing country perspective.

Keywords:  AML; Autoimmune disorders; Haploidentical transplants; Lymphoma; Myeloma; Stem cell transplantation

Year:  2019        PMID： 31388249      PMCID： PMC6646494          DOI： 10.1007/s12288-019-01152-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  10 in total

Review 1.  Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.

Authors:  Keith M Sullivan; Navneet S Majhail; Christopher Bredeson; Paul A Carpenter; Soumya Chatterjee; Leslie J Crofford; George E Georges; Richard A Nash; Marcelo C Pasquini; Stefanie Sarantopoulos; Jan Storek; Bipin Savani; E William St Clair
Journal:  Biol Blood Marrow Transplant       Date:  2018-06-25       Impact factor: 5.742

Review 2.  How I treat refractory chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Adela R Cardones; Keith M Sullivan
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

3.  Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

Authors:  Keith M Sullivan; Ellen A Goldmuntz; Lynette Keyes-Elstein; Peter A McSweeney; Ashley Pinckney; Beverly Welch; Maureen D Mayes; Richard A Nash; Leslie J Crofford; Barry Eggleston; Sharon Castina; Linda M Griffith; Julia S Goldstein; Dennis Wallace; Oana Craciunescu; Dinesh Khanna; Rodney J Folz; Jonathan Goldin; E William St Clair; James R Seibold; Kristine Phillips; Shin Mineishi; Robert W Simms; Karen Ballen; Mark H Wener; George E Georges; Shelly Heimfeld; Chitra Hosing; Stephen Forman; Suzanne Kafaja; Richard M Silver; Leroy Griffing; Jan Storek; Sharon LeClercq; Richard Brasington; Mary E Csuka; Christopher Bredeson; Carolyn Keever-Taylor; Robyn T Domsic; M Bashar Kahaleh; Thomas Medsger; Daniel E Furst
Journal:  N Engl J Med       Date:  2018-01-04       Impact factor: 91.245

Review 4.  Epidemiology and biology of relapse after stem cell transplantation.

Authors:  Mary Horowitz; Hans Schreiber; Alex Elder; Olaf Heidenreich; Josef Vormoor; Christina Toffalori; Luca Vago; Nicolaus Kröger
Journal:  Bone Marrow Transplant       Date:  2018-04-18       Impact factor: 5.483

Review 5.  Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil.

Authors:  Charles Herbaux; Reid Merryman; Steven Devine; Philippe Armand; Roch Houot; Franck Morschhauser; Bradley Haverkos
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

Review 6.  Graft-versus-host disease.

Authors:  David F Moreno; Joan Cid
Journal:  Med Clin (Barc)       Date:  2018-10-09       Impact factor: 1.725

7.  Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial.

Authors:  Uday R Popat; Rohtesh S Mehta; Roland Bassett; Julianne Chen; Benigno C Valdez; Jitesh Kawedia; Sairah Ahmed; Amin M Alousi; Paolo Anderlini; Geath Al-Atrash; Qaiser Bashir; Stefan O Ciurea; Chitra M Hosing; Jin S Im; Roy Jones; Partow Kebriaei; Issa Khouri; David Marin; Yago Nieto; Amanda Olson; Betul Oran; Simrit Parmar; Katayoun Rezvani; Muzaffar H Qazilbash; Nina Shah; Samer A Srour; Elizabeth J Shpall; Richard E Champlin; Borje S Andersson
Journal:  Lancet Haematol       Date:  2018-11       Impact factor: 18.959

8.  Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition.

Authors:  Tomomi Toubai; Hideaki Fujiwara; Corinne Rossi; Mary Riwes; Hiroya Tamaki; Cynthia Zajac; Chen Liu; Anna V Mathew; Jaeman Byun; Katherine Oravecz-Wilson; Ikuo Matsuda; Yaping Sun; Daniel Peltier; Julia Wu; Jiachen Chen; Sergey Seregin; Israel Henig; Stephanie Kim; Stuart Brabbs; Subramaniam Pennathur; Grace Chen; Pavan Reddy
Journal:  Nat Microbiol       Date:  2019-03-11       Impact factor: 17.745

9.  Challenges in managing graft-versus-host disease in developing countries: a perspective.

Authors:  Muhammad Sabih Saleem; Mahmoud Aljurf; Alok Srivastava; Tahir Shamsi; Pei Hua Lu; Amir Ali Hamidieh; Alaa El Haddad; Shahrukh K Hashmi
Journal:  Bone Marrow Transplant       Date:  2018-09-20       Impact factor: 5.483

Review 10.  Novel Therapies and Approaches to Relapsed/Refractory HL Beyond Chemotherapy.

Authors:  Alain Antoine Mina; Chetan Vakkalagadda; Barbara Pro
Journal:  Cancers (Basel)       Date:  2019-03-25       Impact factor: 6.639
  10 in total
  1 in total

1.  Algorithm to Study HLA-Antibodies and Selecting Criteria for the Best Haploidentical Donor.

Authors:  Mar Luis-Hidalgo; Dolores Planelles Silvestre; María Guzmán-Fulgencio; Emma Castro; Carlos Solano
Journal:  Indian J Hematol Blood Transfus       Date:  2020-01-03       Impact factor: 0.900
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.